Regions Financial Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Regions Financial Corp’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,248	Closed	-$201K	–	857
2023 Q4	$201K	Buy	+2,248	New	+$167K	﹤0.01%	790
2022 Q1	–	Sell	-2,201	Closed	-$246K	–	945
2021 Q4	$246K	Buy	+2,201	New	+$265K	﹤0.01%	828
2019 Q2	–	Sell	-840	Closed	-$76K	–	1739
2019 Q1	$76K	Hold	840	–	–	﹤0.01%	1047
2018 Q4	$60K	Hold	840	–	–	﹤0.01%	1097
2018 Q3	$81K	Hold	840	–	–	﹤0.01%	1099
2018 Q2	$80K	Hold	840	–	–	﹤0.01%	1084
2018 Q1	$74K	Buy	840 +47	+6%	+$4.29K	﹤0.01%	1113
2017 Q4	$67K	Buy	+793	New	+$66.4K	﹤0.01%	1161

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Regions Financial Corp's XBI Position: Q1 2024 in Review

Regions Financial Corp sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 2,248 shares — an estimated $201K sold.

Regions Financial Corp first reported a position in XBI in Q4 2017 and held it in 8 quarters. The position peaked at $246K in Q4 2021. 782 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

Regions Financial Corp reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
Regions Financial Corp sold 2,248 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $201K.
Regions Financial Corp first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and held it in 8 quarters.
Regions Financial Corp's State Street SPDR S&P Biotech ETF position peaked at $246K in Q4 2021.
782 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on Regions Financial Corp's 13F filing for Q1 2024, filed 23 Apr 2024.